SGTX - Sigilon Therapeutics GAAP EPS of -$0.27 beats by $0.15 revenue of $4.25M beats by $1.75M November, 10 2022 09:18 AM Sigilon Therapeutics Inc. Sigilon Therapeutics press release ( NASDAQ: SGTX ): Q3 GAAP EPS of -$0.27 beats by $0.15 . Revenue of $4.25M (+117.9% Y/Y) beats by $1.75M . For further details see: Sigilon Therapeutics GAAP EPS of -$0.27 beats by $0.15, revenue of $4.25M beats by $1.75M